Gerald Carlson

Chief Executive Officer en Phibro Animal Health (Belgium) SA .

81 años

Process Industries

Health Technology

Government

Perfil

Gerald K.
Carlson is currently the Chief Executive Officer at Phibro Animal Health (Belgium) SA. Previously, he worked as the Chief Operating Officer & Director at Phibro Animal Health Corp.
from 2014 to 2016.
He also worked as the Senior VP-Corporate Planning & Development at Ecolab, Inc. in 1998 and as the Commissioner-Trade & Development at State of Minnesota from 1999 to 2001.

Cargos activos de Gerald Carlson

Empresas	Cargo	Inicio
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Chief Executive Officer	08/06/2011

Todos los cargos activos de Gerald Carlson

Antiguos cargos conocidos de Gerald Carlson.

Empresas	Cargo	Fin
State of Minnesota	Corporate Officer/Principal	01/01/2001
ECOLAB INC.	Corporate Officer/Principal	01/10/1998
PHIBRO ANIMAL HEALTH CORPORATION	Chief Executive Officer	01/03/2014

Ver el detalle de la experiencia de Gerald Carlson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gerald Carlson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ECOLAB INC.	Process Industries
PHIBRO ANIMAL HEALTH CORPORATION	Health Technology

Empresas privadas	2
State of Minnesota	Government
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Process Industries